It has been shown that p53 inactivation/dysfunction alters the immune landscape of the tumor microenvironment (TME) towards pro-tumor inflammation [37], while cAMP is a potent negative regulator of T cell receptor-mediated activation of effector T cells [38]. Here, TP53 is linked to neoplasm.